If you’ve covered medical research conferences for a while, you know the drill and probably have a variety of tips and tricks already internalized to ensure the experience and your reporting goes as smoothly as possible. If you’re thinking about starting to cover conferences, or preparing to cover your first one, it can be intimidating to know what to expect. Continue reading
Those of us who cover medical studies on a regular basis are always looking for ways to uncover new and interesting research aside from the embargoed releases from the major journals and services such as EurekAlert! Using alerts on PubMed is one option, and now there’s a new app called Case.
I first learned about the app in March when Avikk Ghose, Case’s CEO and co-founder, reached out to me on email. I checked out the app at the time but found some features limited for the way I specifically look for research. (Since it’s aimed at researchers themselves, it was at the time still too hyperspecific for me as a journalist.) Continue reading
Eleven journalists have been chosen for the fourth class of the AHCJ Fellowship on Comparative Effectiveness Research. The fellowship program was created with support from the Patient-Centered Outcomes Research Institute to help reporters and editors produce more accurate in-depth stories on medical research and how medical decisions are made.
The fellows will gather in Washington, D.C., the week of Oct. 7 for a series of presentations, roundtables, how-to database sessions and interactions with researchers.
I just returned from the Logan Science Journalism Fellowship program at Marine Biological Laboratory in Woods Hole, Mass., and I’m excited to share some of the things I learned while there. The program itself — which I highly encourage folks to apply to — is different from any other health or science journalism program I’m aware of because there’s pretty much no journalism involved at all. Instead, it’s basic science that journalism fellows do. Continue reading
Alzheimer’s disease is the sixth leading cause of death in the U.S. Despite decades of research, there’s still no cure, and few options to slow or minimize symptoms. The last Alzheimer’s drug was approved more than 15 years ago, but a new campaign, called Disrupting Dementia, hopes to drive new diagnostics and treatments while also supporting patients and families affected by this devastating condition.
Every journalist covering medical and other types of scientific research should read this thought-provoking open-access article recently published in PNAS: “Crisis or self-correction: Rethinking media narrative about the well-being of science.”
This piece by Kathleen Hall Jamieson of the Annenberg School for Communication at the University of Pennsylvania is one of the best articles I’ve read about how to think about the big picture in our coverage of medicine and science and the public perception of media narratives about science. It’s one of those rare, important writings whose entire purpose is to examine the nuance that’s missing – yet essential – in the majority of science and medicine coverage. Continue reading